首页 | 本学科首页   官方微博 | 高级检索  
     

结核性胸膜炎患者外周血及胸水中Th17细胞和白细胞介素-17水平变化
引用本文:黄小琪,陈晶,林英辉,陈松林,李生,潘元平. 结核性胸膜炎患者外周血及胸水中Th17细胞和白细胞介素-17水平变化[J]. 中国基层医药, 2012, 19(9): 1286-1287
作者姓名:黄小琪  陈晶  林英辉  陈松林  李生  潘元平
作者单位:1. 广西中医学院第一附属医院分子生物学实验室,广西壮族自治区南宁,530023
2. 广西中医学院第一附属医院检验科,广西壮族自治区南宁,530023
基金项目:广西壮族自治区科学基金资助项目
摘    要:目的 探讨结核性胸膜炎外周血和胸水中Th17细胞和白细胞介素-17(IL-17)的表达水平及临床意义.方法 初治结核性胸膜炎(结核组)患者30例和非结核性胸膜炎(胸膜炎组)20例,另选择健康体检人员(对照组)20例.采用流式细胞术和双抗体夹心免疫酶标法(ELISA)测定血清及胸水中Th17细胞的百分率及IL-17的含量.结果 结核组外周血中Th17细胞的百分比和IL-17的含量显著高于对照组和胸膜炎组(P<0.05).结核组胸水中Th17细胞的百分比和IL-17的含量明显高于胸膜炎组(P<0.05).结核组患者在规则治疗1、3、7、14 d时,外周血和胸水中Th17细胞的百分比和IL-17的含量均逐渐下降,外周血中TH17细胞的百分比于治疗1d时显著低于入院时水平(P<0.05),胸水中Th17细胞的百分比于治疗3d时显著低于入院时水平(P<0.05),外周血中IL-17的含量于治疗3d时显著低于人院时水平(P<0.05),胸水中IL-17的含量于治疗7d时显著低于入院时水平(P<0.05).结论 Th17/IL-17参与了结核性胸膜炎的发病机制,且与其病程发展及治疗效果密切相关.

关 键 词:结核性胸膜炎  白细胞介素-17  Th17细胞  胸腔积液

The blood and chest fluid expression levels and significance of Th17 cell and IL-17 in patients with tuberculous pleural effusion
HUANG Xiao-qi , CHEN Jing , LIN Ying-hui , CHEN Song-lin , LI Sheng , PAN Yuan-ping. The blood and chest fluid expression levels and significance of Th17 cell and IL-17 in patients with tuberculous pleural effusion[J]. Chinese Journal of Primary Medicine and Pharmacy, 2012, 19(9): 1286-1287
Authors:HUANG Xiao-qi    CHEN Jing    LIN Ying-hui    CHEN Song-lin    LI Sheng    PAN Yuan-ping
Affiliation:. Department of Molecular Biology Laboratory, the First Affiliated Hospital of Traditional Chinese Medicine College, Guangxi 530023, China
Abstract:Objective To investigate the blood and chest fluid level of Thl7 cell and IL-17 in patients with tuberculous pleural effusion and its pathological role. Methods Flow cytometry and enzyme linked immunosorbent assay (ELISA) were used to measure the blood and chest fluid level of Thl7 cell and IL-17 from 30 patients with tu- berculous pleura] effusion, 20 patients without tuberculous pleura] effusion, and 20 healthy persons. Results The blood level of Thl7 cell and IL-17 were higher in tuberculous pleural effusion than in the other two groups (P 〈 0.05 ). The chest fluid level of Thl7 cell and IL-17 in patients with tuberculous pleural effusion were significantly higher than those in patients without tuberculous pleural effusion ( P 〈 0.05 ). The chest fluid level of Thl7 cell and IL-17 in patients with and without tuberculous pleural effusion were significantly higher than that of the blood serum level. After treatment for 1,3,7 and 14 days,the blood serum and chest fluid level of Thl7 cell and IL-17 were obvi- ously lower. (P 〈 0.01 ). After treatment for 1 day, the blood level of Thl7 cell was obviously lower than before treat- ment (P 〈 0.01 ). After treatment for 3 days, the chest fluid level of Thl7 cell was obviously lower than before treat- ment ( P 〈 0.01 ). After treatment for 3 days, the blood serum level of IL-17 was obviously lower than before treatment ( P 〈 0.01 ). After treatment for 7 days, the chest fluid level of IL-17 was obviously lower than before treatment ( P 〈 0. 01 ). Conclusion Thl7 cell and IL-17 might play an important role in the pathogenesis of tuberculous pleural effu- sion and they were correlated with disease progression and the therapeutic effect.
Keywords:tuberculous pleural elfusion  IL-17  Th17 cell  Pleural effusion
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号